Pharmaceutical composition comprising a cdk inhibitor and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2502979

A first aspect of the invention relates to a combination comprising a CDK inhibitor and gemcitabine. A second aspect of the invention relates to a pharmaceutical product comprising a CDK inhibitor and gemcitabine as a combined preparation for simultaneous, sequential or separate use in therapy. A third aspect of the invention relates to a method of treating a proliferative disorder, said method comprising simultaneously, sequentially or separately administering a CDK inhibitor and gemcitabine to a subject.

Un premier aspect de l'invention concerne une combinaison de gemcitabine et d'un inhibiteur de CDK. Un deuxième aspect de cette invention concerne un produit pharmaceutique à base de gemcitabine et d'un inhibiteur de CDK comme préparation combinée à usage thérapeutique séparé, séquentiel ou simultané. Un troisième aspect de ladite invention concerne une méthode de traitement d'un trouble de prolifération cellulaire, laquelle méthode consiste à administrer de façon séparée, séquentielle ou simultanée un produit à base de gemcitabine et d'un inhibiteur de CDK à un patient.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition comprising a cdk inhibitor and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition comprising a cdk inhibitor and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising a cdk inhibitor and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1621738

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.